OFI
18.6.2024 11:33:26 CEST | Business Wire | Press release
ofi, a leading supplier of naturally good food and beverage ingredients, today unveiled a new sustainability strategy – ‘Choices for Change’ and ambitious 2030 targets.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240618240708/en/
Choices for Change - new ofi sustainability strategy (Photo: ofi)
Global food brands and retailers are facing growing consumer demand for sustainable products, with increasing weather related and other challenges in the food supply chain and significant new sustainability linked legislation coming up. With ‘Choices for Change’, ofi will provide these companies and their consumers with specific choices to deliver long-term impact across four critical pillars: Prosperous Farmers, Thriving Communities, Climate Action, and Regenerating the Living World.
Every 2030 target in the Choices for Change strategy delivers on key customer needs, including:
- Delivering enhanced livelihood support to one million farmers, helping them to be more productive and deliver better quality ingredients.
- Cutting scope 3 emissions by 30% to offer customers verifiable, low-carbon products and ingredients and contribute to net-zero commitments.
- Bringing 2 million hectares of land under regenerative farming practices to create long-term farm resilience and products with verified positive natural impact.
To give customers more rigorous, verifiable data for sustainability decision-making and reporting, the strategy incorporates a focus on supply chain excellence. This brings traceability, data insights, risk mitigation, verification, and in-depth supplier engagement together to enable the right choices and includes ofi’s suite of award-winning tech tools like AtSource - the sustainability management system and its built in Carbon Scenario Planner for planning and costing climate action.
Launching Choices for Change on UN Sustainable Gastronomy Day, Roel van Poppel, Chief Sustainability Officer, ofi, said: “Choices for Change is the next phase in our journey, building upon and reinforcing years of experience in managing sustainability programs spanning hundreds of farming communities. Our team of over 500 sustainability experts from Côte d’Ivoire to Brazil, from Vietnam to Ghana, bring a deep understanding of and capability to solve some of the key environmental and humanitarian challenges in the food system. We offer our customers and partners the traceability, insights, capability, and choices to drive positive change.”
ofi’s leading global product platforms - cocoa, coffee, dairy, nuts, and spices - already have specific strategies or programs to address the challenges and opportunities of each product supply chain1. These strategies will be integral to delivering the targets under Choices for Change which seeks to consolidate a single set of ambitions to be implemented globally, with universal metrics and definitions for all of ofi’s operations across ~50 countries. It will be delivered in partnership with farmers, governments, civil society and ofi’s customers – including many of the world’s largest food retailers, brands, and manufacturers. ofi has a long history of partnering with customers to deliver shared sustainability goals and scale impact, with over 130 collaborative programs active today.
CEO of ofi, A. Shekhar, said: “We know that doing what’s right for communities and the planet is even more critical to our long-term commercial imperative to deliver the highest quality of food ingredients and solutions to our customers. It equips them with a powerful provenance narrative for their consumers, the people who enjoy delicious, high-quality and sustainable food and beverage products every day around the world.”
Today, ofi will be joined by Mars, the U.S. Agency for International Development, and the Sustainable Food Lab at an Innovation Forum event ‘Making Choices for Change in the global food system’2 to discuss how the food value chain can work together to make better choices at every stage from plant to palate.
The new Choices for Change strategy and the detailed ambitions supporting it can be accessed on ofi’s website.
References
- ofi's existing product-focused sustainability strategies include Cashew Trail, Cocoa Compass, Coffee LENS, Hazelnut Trail, Almond Trail and Dairy Tracks
- Register for the webinar free here.
About ofi
ofi (olam food ingredients) is a new operating group born out of Olam Group. ofi offers sustainable, natural, value-added food products and ingredients so that consumers can enjoy the healthy and indulgent products they love. It consists of industry-leading businesses of cocoa, coffee, dairy, nuts, and spices. ofi has built a unique global value chain presence including its own farming operations, farm-gate origination, and manufacturing facilities. ofi partners with customers, leveraging its complementary and differentiated portfolio of ‘on-trend’ food products, to co-create solutions that anticipate and meet changing consumer preferences as demand increases for healthier food that’s traceable and sustainable. To subscribe to the ofi newsroom, please visit www.ofi.com/news-and-events (privacy statement here). If you do not wish to receive information from ofi please contact media@ofi.com. Follow @ofi-group on LinkedIn.
About Olam
Olam Group is a leading food and agri-business supplying food, ingredients, feed, and fibre to 20,200 customers worldwide. More information on Olam can be found at www.olamgroup.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240618240708/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
